Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Pertussis Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.0% during the forecast period.
This report presents the market size and development trends by detailing the Pertussis Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pertussis Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pertussis Vaccine industry and will help you to build a panoramic view of the industrial development.
Pertussis Vaccine Market, By Type:
Whole-cell vaccines
Acellular vaccines
Pertussis Vaccine Market, By Application:
Children
Adults
Some of the leading players are as follows:
Sanofi Pasteur
Astellas Pharma
GSK
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Pertussis Vaccine Market: Technology Type Analysis
-
4.1 Pertussis Vaccine Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Pertussis Vaccine Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Whole-cell vaccines
4.3.2 Acellular vaccines
5 Pertussis Vaccine Market: Product Analysis
-
5.1 Pertussis Vaccine Product Market Share Analysis, 2018 & 2026
-
5.2 Pertussis Vaccine Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Pertussis Vaccine Market: Application Analysis
-
6.1 Pertussis Vaccine Application Market Share Analysis, 2018 & 2026
-
6.2 Pertussis Vaccine Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Children
6.3.2 Adults
7 Pertussis Vaccine Market: Regional Analysis
-
7.1 Pertussis Vaccine Regional Market Share Analysis, 2018 & 2026
-
7.2 Pertussis Vaccine Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Sanofi Pasteur
9.1.1 Sanofi Pasteur Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Astellas Pharma
9.2.1 Astellas Pharma Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 GSK
9.3.1 GSK Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Wuhan Institute of Biological Products
9.4.1 Wuhan Institute of Biological Products Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Changchun Changsheng Life Sciences
9.5.1 Changchun Changsheng Life Sciences Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Minhai Biotechnology
9.6.1 Minhai Biotechnology Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Mitsubishi Tanabe Pharma
9.7.1 Mitsubishi Tanabe Pharma Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
The List of Tables and Figures (Totals 86 Figures and 140 Tables)
Figure Whole-cell vaccines Pertussis Vaccine market, 2015 - 2026 (USD Million)
Figure Acellular vaccines Pertussis Vaccine market, 2015 - 2026 (USD Million)
Figure Children market, 2015 - 2026 (USD Million)
Figure Adults market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Pertussis Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table North America Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table North America Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table North America Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Canada Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Canada Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Europe Pertussis Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Europe Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Europe Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Europe Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Germany Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Germany Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table France Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table France Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Italy Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Italy Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Spain Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Spain Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pertussis Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table China Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table China Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Japan Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Japan Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table India Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table India Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Pertussis Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table MEA Pertussis Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table MEA Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table MEA Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table MEA Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Pertussis Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Pertussis Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Pertussis Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Astellas Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GSK Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Wuhan Institute of Biological Products Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Changchun Changsheng Life Sciences Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Minhai Biotechnology Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
